文献速递消化道肿瘤与早癌消化内镜

内镜活检采样方法与胃癌前驱病变检出率的关联

Association of endoscopic biopsy sampling methods with detection of precursor lesions of gastric cancer.
PubMed 文献 · Gastrointest Endosc · 2023-09-17

该病例对照研究纳入2010至2021年美国多种族医疗系统中接受食管胃十二指肠镜活检的成人患者,比较4种活检采样方法对胃肠化生(GIM)和胃异型增生(GD)检出率的关联。结果显示2+2方案和悉尼方案与GIM检出率升高相关,悉尼方案与GD检出率升高相关,且悉尼方案使用率呈上升趋势。

要点

  • 2+2方案和悉尼方案与胃肠化生检出率升高相关。
  • 悉尼方案与胃异型增生检出率升高相关。
  • 研究期间悉尼方案使用率呈上升趋势。

核心结论

  • 悉尼方案的应用与常规临床实践中胃癌前驱病变检出率增加相关。

研究设计与样本

  • 病例对照研究,纳入2010至2021年美国种族和民族多样性医疗系统中接受食管胃十二指肠镜活检的成人患者。
  • 病例为组织病理学诊断为胃肠化生和/或胃异型增生的患者,对照按年龄、操作日期和医疗中心1:1匹配。
  • 识别出20,938对胃肠化生匹配对和455对胃异型增生匹配对。
  • 比较4种活检采样方法:未指定、指定胃部位、2+2和悉尼方案。
  • 使用Cochrane-Armitage检验评估采样方法使用趋势,使用logistic回归识别与采样方法使用相关的患者和内镜医师因素。

主要发现

  • 胃肠化生病例中采用2+2方案的比例为31.3%,对照组为25.3%(P < .0001)。
  • 胃肠化生病例中采用悉尼方案的比例为9.1%,对照组为1.0%(P < .0001)。
  • 胃异型增生病例中采用悉尼方案的比例为15.6%,对照组为0.4%(P < .0001)。
  • 研究期间悉尼方案使用率在病例中从3.8%升至16.1%(P < .0001),在对照组中从1%升至1.1%(P = .005)。
  • 男性和亚裔美国患者更可能接受2+2或悉尼方案,女性和西班牙裔内镜医师更可能使用这些方案进行采样。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The yield of various endoscopic biopsy sampling methods for detection of precursor lesions of noncardia gastric cancer in a real-world setting remains unclear. Our objective was to evaluate the association of endoscopic biopsy sampling methods with detection of gastric intestinal metaplasia (GIM) and gastric dysplasia (GD). METHODS: We conducted a case-control study of adult patients who underwent EGD with biopsy sampling between 2010 and 2021 in a racially and ethnically diverse U.S. healthcare system. Cases were patients with histopathologic findings of GIM and/or GD. Control subjects were matched 1:1 by age, procedure date, and medical center. We compared the detection of GIM and GD using 4 different biopsy sampling methods: unspecified, specified stomach location, 2+2, and the Sydney protocol. Additionally, we assessed trends in use of sampling methods (Cochrane-Armitage) and identified patient and endoscopist factors associated with their use (logistic regression). RESULTS: We identified 20,938 GIM and 455 GD matched pairs. A greater proportion of GIM cases were detected using 2+2 (31.3% vs 25.3%, P < .0001) and the Sydney protocol (9.1% vs 1.0%, P < .0001) compared with control subjects. Similarly, a greater proportion of GD cases were detected using the Sydney protocol (15.6% vs .4%, P < .0001). We observed an increasing trend in the use of the Sydney protocol during the study period (3.8%-16.1% in cases, P < .0001; 1%-1.1% in control subjects, P = .005). Male and Asian American patients were more likely to undergo 2+2 or the Sydney protocol, whereas female and Hispanic endoscopists were more likely to perform sampling using these protocols. CONCLUSIONS: The application of the Sydney protocol is associated with an increased detection of precursor lesions of gastric cancer in routine clinical practice.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Moon RH, Puttock EJ, Chen W, et al. Association of endoscopic biopsy sampling methods with detection of precursor lesions of gastric cancer. Gastrointest Endosc. 2023. PMID: 37717603. doi:10.1016/j.gie.2023.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。